Showing results (1691-1700 of 1,800) with videos related to
Sort By:
Pageof 180
Annals of the Rheumatic Diseases|April 5, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosusC Gordon, G Bertsias, J P A Ioannidis, et al.Journal of Hepatology|April 17, 2017
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosisPaul Y Kwo, Fred Poordad, Armen Asatryan, et al.Hepatology Communications|January 29, 2024
African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitisMaryam Yazdanfar, Joseph Zepeda, Richard Dean, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2026
Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty SurveyTatyana Kushner, Maria Buti, Mohamed El-Kassas, et al.Annals of the Rheumatic Diseases|November 7, 2009
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studiesM Mosca, C Tani, M Aringer, et al.Annals of the Rheumatic Diseases|June 5, 2007
The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort studyS Bernatsky, L Joseph, J-F Boivin, et al.The New England Journal of Medicine|April 24, 2013
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment optionsIra M Jacobson, Stuart C Gordon, Kris V Kowdley, et al.Journal of Hepatology|December 24, 2013
Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null responseJohn M Vierling, Mitchell Davis, Steven Flamm, et al.Journal of Gastroenterology and Hepatology|July 8, 2026
Chronic Viral Hepatitis With MASLD: Implications for Clinical and Patient-Reported OutcomesGeorge Papatheodoridis, Maria Buti, Yusuf Yilmaz, et al.Annals of the Rheumatic Diseases|September 14, 2010
An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENAD A Isenberg, E Allen, V Farewell, et al.Pageof 180